A case control study of sarcosine as an early prostate cancer detection biomarker

par Ankerst, Donna P., Liss, Michael, Zapata, David, Hoefler, Josef, Thompson, Ian M., Leach, Robin J.
Publié dans BMC Urol (2015)

PROSTATE CANCER PREVENTION TRIAL RISK CALCULATOR 2.0 FOR THE PREDICTION OF LOW- VERSUS HIGH-GRADE PROSTATE CANCER

par Ankerst, Donna P., Hoefler, Josef, Bock, Sebastian, Goodman, Phyllis J., Vickers, Andrew, Hernandez, Javier, Sokoll, Lori J., Sanda, Martin G., Wei, John T., Leach, Robin J., Thompson, Ian M.
Publié 2014

PRECISION MEDICINE IN ACTIVE SURVEILLANCE FOR PROSTATE CANCER: DEVELOPMENT OF THE CANARY-EDRN ACTIVE SURVEILLANCE BIOPSY RISK CALCULATOR (ABC)

par Ankerst, Donna P., Xia, Jing, Thompson, Ian M., Hoefler, Josef, Newcomb, Lisa F., Brooks, James D., Carroll, Peter R., Ellis, William J., Gleave, Martin E., Lance, Raymond S., Nelson, Peter S., Wagner, Andrew A., Wei, John T., Etzioni, Ruth, Lin, Daniel W.
Publié dans Eur Urol (2015)

A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors

par de Braud, Filippo, Machiels, Jean-Pascal H., Boggiani, Daniela, Rottey, Sylvie W.H., Duca, Matteo, Laruelle, Marie, Salvagni, Stefania, Damian, Silvia, Lapeire, Lore D.F., Tiseo, Marcello, Dermine, Alexandre, Ould-Kaci, Mahmoud, Braunger, Juergen, Rascher, Juliane, Fischer, Daniela, Hoefler, Josef, Mariani, Gabriella L., Cresta, Sara
Publié dans Cancers (Basel) (2020)